【発明の名称】タルトロン酸類、それらのアセタリックエーテル類及びO-エステル類

Japanese Patent JPH08503195

A

PCT No. PCT/EP93/02941 Sec. 371 Date May 23, 1995 Sec. 102(e) Date May 23, 1995 PCT Filed Oct. 25, 1993 PCT Pub. No. WO94/10127 PCT Pub. Date May 11, 1994Tartronic acid acetalic ethers and esters of the general formula: are provided and are useful in treatment of bone dysmetabolism. As examples, Ra and Rb may be hydrogen, B is a C2-C12 acyl group, R is phenyl and n is 0-12.

Gandwolf, Carmelo, Ah.
Kourtini, Lourera
Mantou Vaniniy, Marco
Kaseri, Gian Francow
Claverner, Gaeter Know
Oumiinii, Claudio

JP51066193A

April 09, 1996

October 25, 1993

Click for automatic bibliography generation  

Don Phe Pharmatsu Eutichii Es. P.A.

A61K31/19; A61K31/215; A61K31/335; A61K31/34; A61K31/341; A61K31/35; A61K31/351; A61K31/357; A61K31/38; A61K31/381; A61K31/39; A61K31/40; A61K31/425; A61K31/426; A61K31/44; A61K31/4409; A61K31/4418; A61K31/443; A61K31/445; A61K31/47; A61K31/535; A61K31/5375; A61P3/02; A61P19/10; A61P43/00; C07C59/11; C07C67/31; C07C67/343; C07C69/67; C07C69/73; C07C69/732; C07C211/63; C07C229/24; C07C271/22; C07C323/62; C07D207/08; C07D295/10; C07D211/14; C07D211/22; C07D211/34; C07D213/55; C07D215/14; C07D215/18; C07D277/14; C07D277/20; C07D277/34; C07D295/15; C07D307/54; C07D309/12; C07D311/16; C07D317/30; C07D319/12; C07D327/06; C07D333/24; C07D405/04; C07D405/12; C07D405/14; (IPC1-7): C07C59/11; A61K31/19; A61K31/215; A61K31/335; A61K31/34; A61K31/35; A61K31/38; A61K31/39; A61K31/40; A61K31/425; A61K31/44; A61K31/445; A61K31/47; A61K31/535; C07C67/31; C07C67/343; C07C69/67; C07C69/73; C07C69/732; C07C211/63; C07C271/22; C07C323/62; C07D207/08; C07D211/14; C07D211/22; C07D213/55; C07D215/14; C07D277/34; C07D295/10; C07D307/54; C07D309/12; C07D319/12; C07D327/06; C07D333/24; C07D405/04; C07D405/14

Wakabayashi Tadashi

Previous Patent: ライム病の診断および予防に有用な組成物

Next Patent: 共役ジエンの二量化法